Literature DB >> 18640436

Dimebon in Alzheimer's disease: old drug for new indication.

Alistair Burns1, Robin Jacoby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18640436     DOI： 10.1016/S0140-6736(08)61046-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Authors:  Krista L Lanctôt; Ryan D Rajaram; Nathan Herrmann
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

Review 2.  Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.

Authors:  Michela Rosini; Elena Simoni; Anna Minarini; Carlo Melchiorre
Journal:  Neurochem Res       Date:  2014-02-04       Impact factor: 3.996

3.  Can Drug Repositioning Work as a Systematical Business Model?

Authors:  Jianan Huang
Journal:  ACS Med Chem Lett       Date:  2020-04-17       Impact factor: 4.345

4.  Development of proneurogenic, neuroprotective small molecules.

Authors:  Karen S MacMillan; Jacinth Naidoo; Jue Liang; Lisa Melito; Noelle S Williams; Lorraine Morlock; Paula J Huntington; Sandi Jo Estill; Jamie Longgood; Ginger L Becker; Steven L McKnight; Andrew A Pieper; Jef K De Brabander; Joseph M Ready
Journal:  J Am Chem Soc       Date:  2011-01-06       Impact factor: 15.419

5.  Discovery of a proneurogenic, neuroprotective chemical.

Authors:  Andrew A Pieper; Shanhai Xie; Emanuela Capota; Sandi Jo Estill; Jeannie Zhong; Jeffrey M Long; Ginger L Becker; Paula Huntington; Shauna E Goldman; Ching-Han Shen; Maria Capota; Jeremiah K Britt; Tiina Kotti; Kerstin Ure; Daniel J Brat; Noelle S Williams; Karen S MacMillan; Jacinth Naidoo; Lisa Melito; Jenny Hsieh; Jef De Brabander; Joseph M Ready; Steven L McKnight
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

6.  NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.

Authors:  Ivan Goussakov; Megan B Miller; Grace E Stutzmann
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

Review 7.  The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Authors:  Junghee Lee; Jung Hyun Boo; Hoon Ryu
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

Review 8.  APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

Authors:  Susan Bookheimer; Alison Burggren
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

9.  Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer.

Authors:  Yu-Chan Wang; Rong-Hong Zhang; Sheng-Cao Hu; Hong Zhang; Dan Yang; Wen-Li Zhang; Yong-Long Zhao; Dong-Bing Cui; Yong-Jun Li; Wei-Dong Pan; Shang-Gao Liao; Meng Zhou
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

Review 10.  Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.

Authors:  P R Bharadwaj; K A Bates; T Porter; E Teimouri; G Perry; J W Steele; S Gandy; D Groth; R N Martins; Giuseppe Verdile
Journal:  Transl Psychiatry       Date:  2013-12-03       Impact factor: 6.222
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.